Internal Medicine, Hematology & Oncology · Charlotte, NC
NPI
1417105941
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
474 services
Medicare patients, 2024
169
Average age 73
Drug cost, 2024
$37K
563 prescriptions
Company payments, 2025
$318K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shebli Atrash was code 99214 (office e&m - established), 231 times for 101 patients. In total Shebli Atrash billed 474 services in 18 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 231 | 101 | $65.41 | $15K |
| 99213 Office E&M - Established | Facility | 81 | 52 | $40.63 | $3,291 |
| 99214 Office E&M - Established | Office | 47 | 28 | $69.66 | $3,274 |
By year: 2022 $32K for 427 services; 2023 $28K for 402 services; 2024 $30K for 474 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shebli Atrash prescribed most often to Medicare patients was Acyclovir, with 147 prescriptions and refills. In total Shebli Atrash wrote 563 Medicare prescriptions that cost $37K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 147 | 275 | 40 | $1,882 |
| Oxycodone Hcl Generic | 32 | 32 | 14 | $447 |
| Ondansetron Hcl Generic | 30 | 30 | 18 | $161 |
| Gabapentin Generic | 30 | 41 | Under 11 | $393 |
| Dexamethasone Generic | 26 | 30 | 16 | $450 |
| Eliquis Apixaban | 20 | 31 | Under 11 | $16K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 19 | Under 11 | $174 |
| Tramadol Hcl Generic | 15 | 15 | Under 11 | $118 |
| Twinrix Hepatitis A And B Vaccine/Pf | 15 | 15 | Under 11 | $2,025 |
| Omeprazole Generic | 15 | 31 | Under 11 | $115 |
| Pentacel Dipht,pert(A),tet-Polio/Hib/Pf | 15 | 15 | Under 11 | $1,843 |
| Trazodone Hcl Generic | 13 | 17 | Under 11 | $75.76 |
Brand drugs: 84 claims; generic drugs: 479 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shebli Atrash $318K ($318K in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $307K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $307K |
| GlaxoSmithKline, LLC. GSK | 1 | $7,250 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $1,675 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $710 |
| Janssen Biotech, Inc. JNJ | 7 | $689 |
| Karyopharm Therapeutics Inc. KPTI | 1 | $408 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $114 |
| AstraZeneca UK Limited AZN | 1 | $96.21 |
| Janssen Research & Development, LLC JNJ | 2 | $80 |
| Legend Biotech USA Inc. LEGN | 1 | $18.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.